Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin B Substitution in HIV-infected Individuals
NCT02773147Phase 2Unknown
- Sponsor
- University of Gothenburg
- Start
- Apr 2016
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Triobe in hyperhomocysteinemia (2 arms), sponsored by University of Gothenburg. Primary endpoint: Neurofilament Light Protein at 1 year. Status: unknown.
02
Drugs
Triobe
03
Conditions
hyperhomocysteinemia
Beyond the preview
Go deeper on NCT02773147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02773147.